disponibile in formato PDF - Stampa alternativa

■ Muller-Vahl, K.R., et al., “Influence of Treatment of Tourette Syndrome with
Delta9-tetrahydrocannabinol (delta9-THC) on Neuropsychological
Performance”, in: Pharmacopsychiatry, Jan;34(1), 2001, pp. 19-24.
■ Muller-Vahl, K.R., et al., “Treatment of Tourette-Syndrome with Delta-9tetrahydrocannabinol
(THC): a Randomized Crossover Trial”, in:
Pharmacopsychiatry, (in corso di stampa).
■ Munson, A.E., Harris, L.S.., Friedman, M.A., Dewey, W.L., Carchman, R.A.,
“Antineoplastic Activity of Cannabinoids”, in: J Natl Cancer Inst, vol. 55, 1975,
pp. 597-602.
■ Nagayama, T., Sinor, A.D., Simon, R.P., et al., “Cannabinoids and
Neuroprotection in Global and Focal Cerebral Ischemia and in Neuronal
Cultures”, in: J. of Neurosciences, vol. 19, 1999, pp. 2887-2895.
■ National Institutes of Health, Workshop on the Medical Utility of Marijuana:
Report to the Director, Washington, D.C., 1997.
■ Neeleman, P.M.P., “Effects of Delta9-tetrahydrocannabinol and Other
Cannabinoids on Pain”, in: E.S.A. Annual Meeting, Vienna, 2000, pp. 139-142.
Neff, G.W., et al., “Preliminary Observation with Dronabinol in Patients with
Intractable Pruritus Secondary to Cholestatic Liver Disease”, in: Am J Gastroenterol,
vol. 97, 2002, pp. 2117-2119.
■ Notcutt, W., et al., “Medicinal Cannabis Extract in Chronic Pain: Design of a
Comparative ‘n of 1’ Primary Study”, in: IRCS Annual Symposium on the
Cannabinoids, Abstracts, 2002, (disponibile su http://www.cannabinoidsociety.org)
■ Noyes, R., Brunk, S.F., Avery, D.A., Canter, A.C., “The Analgesic Properties
of D9-tetrahydrocannabinol and Codeine”, in: Clin. Phar. Ther., vol. 18, 1975,
pp. 84-89.
■ O’Shaughnessy, W.B., “On the Preparations of the Hemp, or Gunjah
(Cannabis indica): the Effects on the Animal System”, in: Health. Trans. of the
Med. and Phys. Society of Bengal, 1838-40, pp. 421-61.
■ Panerai, A.E., I cannabinoidi in terapia del dolore, Congresso nazionale
A.I.S.D., Grado, 2000, pp. 23-27.
■ Pate, D.W., “Glaucoma and Cannabinoids”, in: Grotenhermen, F., Russo, E.,
(a cura di), Cannabis and Cannabinoids. Pharmacology, Toxicology, and
Therapeutic Potential, Haworth Press, Binghamton, New York, 2002, p. 221-
230.
■ Petro, D.J., Ellenberger, C., “Treatment of Human Spasticity with
Tetrahydrocannabinol”, in: Journal of Clinical Pharmacology, vol. 21, 1981, pp.
413-416.
■ Petro, D., “Spasticity and Chronic Pain”, in: Mathre, M.L., (a cura di),
Cannabis in Medical Practice, Jefferson, NC, McFarland, 1997.
■ Pharmos Corporation, Press Release, 2002, July 25.
■ Porcella, A., Casellas, P., Gessa, G.L., Pani, L., “Cannabinoid Receptor CB1
mRNA Is Highly Expressed in the Rat Ciliary Body: Implications for the
134